Evidence map›Paper›PMID 32568415›Full record

ArticleImmunology and cell biology2020

The MAIT TCRβ chain contributes to discrimination of microbial ligand.

Gitanjali A Narayanan, James E McLaren, Erin W Meermeier, Kristin Ladell, Gwendolyn M Swarbrick, David A Price, Jessica G Tran, Aneta H Worley, Todd Vogt, Emily B Wong and 1 more

Abstract read
In one paragraph

Article in Immunology and cell biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Atypical TRAV1-2The Journal of biological chemistry · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Gitanjali A NarayananDepartment of Pulmonary and Critical Care Medicine, Oregon Health & Science University, Portland, OR, USA.ORCID 0000-0003-4371-8170
James E McLarenDivision of Infection and Immunity, Cardiff University School of Medicine, Heath Park, Cardiff, UK.ORCID 0000-0002-7021-5934
Erin W MeermeierDepartment of Pulmonary and Critical Care Medicine, Oregon Health & Science University, Portland, OR, USA.
Kristin LadellDivision of Infection and Immunity, Cardiff University School of Medicine, Heath Park, Cardiff, UK.ORCID 0000-0002-9856-2938
Gwendolyn M SwarbrickDepartment of Pulmonary and Critical Care Medicine, Oregon Health & Science University, Portland, OR, USA.
David A PriceDivision of Infection and Immunity, Cardiff University School of Medicine, Heath Park, Cardiff, UK.ORCID 0000-0001-9416-2737
Jessica G TranVA Portland Health Care Center, Portland, OR, USA.
Aneta H WorleyVA Portland Health Care Center, Portland, OR, USA.
Todd VogtVA Portland Health Care Center, Portland, OR, USA.
Emily B WongAfrica Health Research Institute, Durban, South Africa.
David M LewinsohnDepartment of Pulmonary and Critical Care Medicine, Oregon Health & Science University, Portland, OR, USA.

Funding

T cell recognition of the MR1 presented microbial metabolomeR01AI147954 · NIAID · UNIVERSITY OF CHICAGO · PI ADAMS, ERIN JUNE, HILDEBRAND, WILLIAM · 2019 to 2023
$7.3M
Multidisciplinary Research Training in Pulmonary MedicineT32HL083808 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI LEWINSOHN, DAVID M., SLATORE, CHRISTOPHER G. · 2008 to 2025
$5.3M
Recognition of Mtb-infected Cells by CD8+ T LymphocytesR01AI048090 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI LEWINSOHN, DAVID M. · 2001 to 2016
$4.2M
Lung Resident, MR1-Restricted T Cells: Association with Differential Outcomes Following Exposure to M. TuberculosisR01AI134790 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI LEWINSOHN, DAVID M., WALZL, GERHARD · 2018 to 2022
$3.3M
Studies of Mucosal Associated Invariant T (MAIT) cells in people with HIV, TB and HIV/TB co-infection in South AfricaK08AI118538 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI WONG, EMILY BETH · 2015 to 2019
$950k
Recognition of Mtb-Infected Cells by Non-Classically Restritcted CD8+ T CellsI01BX000533 · VA · PORTLAND VA MEDICAL CENTER · PI LEWINSOHN, DAVID M. · 2011 to 2024
–
BLRD VA I01 BX000533NHLBI NIH HHS T32 HL083808NIAID NIH HHS K08 AI118538NIAID NIH HHS R01 AI048090NIAID NIH HHS R01 AI134790NIAID NIH HHS R01 AI147954Wellcome TrustWellcome Trust 100326/Z/12/Z
6 · The paper itself

Abstract

Mucosal-associated invariant T (MAIT) cells are key players in the immune response against microbial infection. The MAIT T-cell receptor (TCR) recognizes a diverse array of microbial ligands, and recent reports have highlighted the variability in the MAIT TCR that could further contribute to discrimination of ligand. The MAIT TCR complementarity determining region (CDR)3β sequence displays a high level of diversity across individuals, and clonotype usage appears to be dependent on antigenic exposure. To address the relationship between the MAIT TCR and microbial ligand, we utilized a previously defined panel of MAIT cell clones that demonstrated variability in responses against different microbial infections. Sequencing of these clones revealed four pairs, each with shared (identical) CDR3α and different CDR3β sequences. These pairs demonstrated varied responses against microbially infected dendritic cells as well as against 5-(2-oxopropylideneamino)-6-d-ribitylaminouracil, a ligand abundant in Salmonella enterica serovar Typhimurium, suggesting that the CDR3β contributes to differences in ligand discrimination. Taken together, these results highlight a key role for the MAIT CDR3β region in distinguishing between MR1-bound antigens and ligands.

Indexed as

Genes, T-Cell Receptor betaLymphocyte ActivationMucosal-Associated Invariant T CellsBacterial InfectionsComplementarity Determining RegionsHumansLigandsRibitolUracil5-(2-oxopropylideneamino)-6-d-ribitylaminouracilComplementarity Determining RegionsLigandsRibitolUracilAntimicrobial responsesbacterial host responseT-cell receptor

Identifiers

PMID32568415
PMCPMC7541710

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.